Lazard Asset Management LLC Sells 3,752 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Lazard Asset Management LLC lessened its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 12.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 26,529 shares of the company's stock after selling 3,752 shares during the quarter. Lazard Asset Management LLC owned approximately 0.15% of Addus HomeCare worth $3,325,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Barclays PLC boosted its holdings in shares of Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after buying an additional 29,207 shares in the last quarter. Ellsworth Advisors LLC lifted its stake in Addus HomeCare by 6.5% during the 4th quarter. Ellsworth Advisors LLC now owns 5,692 shares of the company's stock valued at $713,000 after acquiring an additional 348 shares in the last quarter. Sheets Smith Wealth Management raised its stake in shares of Addus HomeCare by 3.2% during the 4th quarter. Sheets Smith Wealth Management now owns 7,005 shares of the company's stock worth $878,000 after purchasing an additional 218 shares during the period. Dakota Wealth Management raised its stake in shares of Addus HomeCare by 24.2% during the 4th quarter. Dakota Wealth Management now owns 2,024 shares of the company's stock worth $254,000 after purchasing an additional 394 shares during the period. Finally, Janney Montgomery Scott LLC raised its stake in shares of Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock worth $1,340,000 after purchasing an additional 91 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Price Performance

ADUS stock traded up $1.42 during trading on Tuesday, hitting $112.51. 184,788 shares of the stock traded hands, compared to its average volume of 165,638. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The firm's 50 day moving average is $100.66 and its two-hundred day moving average is $113.56. The stock has a market cap of $2.07 billion, a price-to-earnings ratio of 25.75, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare's revenue for the quarter was up 20.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.21 EPS. As a group, analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have weighed in on ADUS. Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie boosted their target price on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Stephens reiterated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Addus HomeCare has an average rating of "Buy" and an average target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.